Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
206
-
Total 13F shares, excl. options
-
35M
-
Shares change
-
+2.04M
-
Total reported value, excl. options
-
$637M
-
Value change
-
-$33.9M
-
Put/Call ratio
-
1.34
-
Number of buys
-
101
-
Number of sells
-
-144
-
Price
-
$18.20
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q3 2022
352 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q3 2022.
NOVAVAX INC - Common Stock (NVAX) has 206 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35M shares
of 160M outstanding shares and own 21.86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.5M shares), BlackRock Inc. (4.33M shares), STATE STREET CORP (3.66M shares), CITIGROUP INC (1.43M shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (1.33M shares), GEODE CAPITAL MANAGEMENT, LLC (1.04M shares), CITADEL ADVISORS LLC (1.04M shares), GOLDMAN SACHS GROUP INC (961K shares), CREDIT SUISSE AG/ (938K shares), and RENAISSANCE TECHNOLOGIES LLC (881K shares).
This table shows the top 206 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.